Tumours were allowed to form, and mice (n = 5–7) bearing tumours of ~220 mm3 were treated for 28 days with the EZH2 inhibitor, GSK126, and the ATM inhibitor, AZD1390, or the combination of both drugs (Fig. 4a). Here, EZH2 is linked to neoplasm.